Why Hasn’t Telemedicine Lived Up to the Hype?

In this episode of A Moment in Health, Dr. Ashish Jha shares a striking data point: 46% of Americans believe a recent federal health bill will hurt them and their families. He then spotlights a new New England Journal of Medicine study showing that ivermectin reduced malaria infections by 26% in Kenyan children, underscoring its value for parasitic diseases. Chair of Health Services, Policy and Practice Dr. Ateev Mehrotra joins to discuss why telemedicine has fallen short of expectations and how changes to incentives and regulations could help it deliver on its promise of improved access and lower costs.Dr. Jha discusses:KFF Health Tracking Poll: Public Views on Recent Tax and Budget Legislation — Kaiser Family FoundationIvermectin to Control Malaria — A Cluster-Randomized Trial — New England Journal of MedicineAbout the GuestDr. Ateev Mehrotra is the chair of the Department of Health Services, Policy and Practice at the Brown University School of Public Health. His clinical work has been both as a primary care physician and as an adult and pediatric hospitalist. Much of Dr. Mehrotra's research is focused on delivery innovations such as retail clinics, e-visits, and telemedicine, including their impact on quality, costs, and access to health care.About the HostDr. Ashish K. Jha is the dean of the Brown University School of Public Health.Music by Katherine Beggs, additional music by Lulu West and Maya Polsky